1 Report Prologue
2 Market Introduction
2.1 Introduction 18
2.2 Assumptions & Limitations 18
3 Research Methodology
3.1 Research Process 21
3.2 Primary Research 21
3.3 Secondary Research 22
3.4 Market Size Estimation 22
4 Market Dynamics
4.1 Introduction 24
4.2 Drivers 24
4.2.1 Increasing Prevalence Of Chronic Conditions Such As Diabetes Is Estimated To Increase The Demand
For Needle-Free Injectors 24
4.2.2 Capacity Of Needle-Free Injectors To Support Homecare 24
4.2.3 Growing Biopharmaceuticals Industry 25
4.2.4 Increasing Investments In The Market 25
4.2.5 Drivers Impact Analysis 25
4.3 Restraints 26
4.3.1 Risks Of Cross Contamination 26
4.3.2 High Cost 26
4.3.3 Restraints Impact Analysis 26
4.4 Opportunity 27
4.4.1 Increasing Campaigns Of Vaccination In Developing Economies Of The Asia Pacific Region 27
4.5 Macroeconomic Indicators 27
5 Market Factor Analysis
5.1 Value Chain Analysis 29
5.1.1 R&D & Designing 29
5.1.2 Manufacturing 29
5.1.3 Distribution & Sales 29
5.1.4 Post-Sales Review 30
5.2 Porter’s Five Forces Model 31
5.2.1 Bargaining Power Of Suppliers 31
5.2.2 Bargaining Power Of Buyers 31
5.2.3 Threat Of New Entrants 32
5.2.4 Threat Of Substitutes 32
5.2.5 Intensity Of Rivalry 32
5.3 Investment Opportunities 32
5.4 Pricing Analysis 32
6 Needle Free Injection Market, By Product
6.1 Introduction 34
6.2 Fillable Needle-Free Injectors 35
6.3 Prefilled Needle-Free Injectors 35
7 Needle Free Injection Market, By Technology
7.1 Introduction 37
7.2 Jet-Based 38
7.3 Spring-Based 38
7.4 Laser-Powered 38
8 Global Needle Free Injection Market, By Usability
8.1 Introduction 40
8.2 Reusable Needle-Free Injectors 41
8.3 Disposable Needle-Free Injectors 41
9 Global Needle Free Injection Market, By Type Of Medication
9.1 Introduction 43
9.2 Liquid-Based Needle Free Injectors 44
9.3 Powder-Based Needle Free Injectors 44
9.4 Projectile/Depot-Based Needle Free Injectors 44
10 Needle Free Injection Market, By Site Of Delivery
10.1 Introduction 46
10.2 Intra Dermal Injectors 47
10.3 Intramuscular Injectors 47
10.4 Subcutaneous Injectors 47
11 Needle Free Injection Market, By Application
11.1 Introduction 49
11.2 Vaccination 50
11.3 Insulin Delivery 50
11.4 Oncology 50
12 Needle Free Injection Market, By End Users
12.1 Introduction 52
12.2 Hospitals And Clinics 53
12.3 Ambulatory Surgical Centres 53
12.4 Homecare Settings 53
13 Global Needle Free Injection Market, By Region
13.1 Introduction 55
13.2 Americas 56
Needle Free Injection Market, By Product
Needle Free Injection Market, By Technology
Needle Free Injection Market, By Site Of Delivery
Needle Free Injection Market, By Application
Needle Free Injection Market, By End Users
13.2.1 North America 59
Needle Free Injection Market, By Product
Needle Free Injection Market, By Technology
Needle Free Injection Market, By Site Of Delivery
Needle Free Injection Market, By Application
Needle Free Injection Market, By End Users
13.2.1.1 U.S 61
Needle Free Injection Market, By Product
Needle Free Injection Market, By Technology
Needle Free Injection Market, By Site Of Delivery
Needle Free Injection Market, By Application
Needle Free Injection Market, By End Users
13.2.1.2 Canada 63
Needle Free Injection Market, By Product
Needle Free Injection Market, By Technology
Needle Free Injection Market, By Site Of Delivery
Needle Free Injection Market, By Application
Needle Free Injection Market, By End Users
13.2.2 South America 65
Needle Free Injection Market, By Product
Needle Free Injection Market, By Technology
Needle Free Injection Market, By Site Of Delivery
Needle Free Injection Market, By Application
Needle Free Injection Market, By End Users
13.3 Europe 68
Needle Free Injection Market, By Product
Needle Free Injection Market, By Technology
Needle Free Injection Market, By Site Of Delivery
Needle Free Injection Market, By Application
Needle Free Injection Market, By End Users
13.3.1 Western Europe 71
Needle Free Injection Market, By Product
Needle Free Injection Market, By Technology
Needle Free Injection Market, By Site Of Delivery
Needle Free Injection Market, By Application
Needle Free Injection Market, By End Users
13.3.1.1 Germany 73
Needle Free Injection Market, By Product
Needle Free Injection Market, By Technology
Needle Free Injection Market, By Site Of Delivery
Needle Free Injection Market, By Application
Needle Free Injection Market, By End Users
13.3.1.2 France 75
Needle Free Injection Market, By Product
Needle Free Injection Market, By Technology
Needle Free Injection Market, By Site Of Delivery
Needle Free Injection Market, By Application
Needle Free Injection Market, By End Users
13.3.1.3 U.K 77
Needle Free Injection Market, By Product
Needle Free Injection Market, By Technology
Needle Free Injection Market, By Site Of Delivery
Needle Free Injection Market, By Application
Needle Free Injection Market, By End Users
13.3.1.4 Italy 79
Needle Free Injection Market, By Product
Needle Free Injection Market, By Technology
Needle Free Injection Market, By Site Of Delivery
Needle Free Injection Market, By Application
Needle Free Injection Market, By End Users
13.3.1.5 Spain 81
Needle Free Injection Market, By Product
Needle Free Injection Market, By Technology
Needle Free Injection Market, By Site Of Delivery
Needle Free Injection Market, By Application
Needle Free Injection Market, By End Users
13.3.1.6 Rest Of Western Europe 83
Needle Free Injection Market, By Product
Needle Free Injection Market, By Technology
Needle Free Injection Market, By Site Of Delivery
Needle Free Injection Market, By Application
Needle Free Injection Market, By End Users
13.3.2 Eastern Europe 85
Needle Free Injection Market, By Product
Needle Free Injection Market, By Technology
Needle Free Injection Market, By Site Of Delivery
Needle Free Injection Market, By Application
Needle Free Injection Market, By End Users
13.4 Asia Pacific 88
Needle Free Injection Market, By Product
Needle Free Injection Market, By Technology
Needle Free Injection Market, By Site Of Delivery
Needle Free Injection Market, By Application
Needle Free Injection Market, By End Users
13.4.1 China 91
Needle Free Injection Market, By Product
Needle Free Injection Market, By Technology
Needle Free Injection Market, By Site Of Delivery
Needle Free Injection Market, By Application
Needle Free Injection Market, By End Users
13.4.2 India 93
Needle Free Injection Market, By Product
Needle Free Injection Market, By Technology
Needle Free Injection Market, By Site Of Delivery
Needle Free Injection Market, By Application
Needle Free Injection Market, By End Users
13.4.3 Japan 95
Needle Free Injection Market, By Product
Needle Free Injection Market, By Technology
Needle Free Injection Market, By Site Of Delivery
Needle Free Injection Market, By Application
Needle Free Injection Market, By End Users
13.4.4 South Korea 97
Needle Free Injection Market, By Product
Needle Free Injection Market, By Technology
Needle Free Injection Market, By Site Of Delivery
Needle Free Injection Market, By Application
Needle Free Injection Market, By End Users
13.4.5 Rest Of Asia Pacific 99
Needle Free Injection Market, By Product
Needle Free Injection Market, By Technology
Needle Free Injection Market, By Site Of Delivery
Needle Free Injection Market, By Application
Needle Free Injection Market, By End Users
13.5 Middle East & Africa 102
Needle Free Injection Market, By Product
Needle Free Injection Market, By Technology
Needle Free Injection Market, By Site Of Delivery
Needle Free Injection Market, By Application
Needle Free Injection Market, By End Users
13.6 The Middle East 105
Needle Free Injection Market, By Product
Needle Free Injection Market, By Technology
Needle Free Injection Market, By Site Of Delivery
Needle Free Injection Market, By Application
Needle Free Injection Market, By End Users
13.6.1 Africa 107
Needle Free Injection Market, By Product
Needle Free Injection Market, By Technology
Needle Free Injection Market, By Site Of Delivery
Needle Free Injection Market, By Application
Needle Free Injection Market, By End Users
14 Competitive Landscape
14.1 Introduction 111
14.2 Recent Developments, 2014–2018 111
15 Company Profiles
15.1 Antares Pharma Inc. 114
15.1.1 Company Overview 114
15.1.2 Financial Overview 114
15.1.3 Products Offering 115
15.1.4 Key Developments 115
15.1.5 SWOT Analysis 115
15.1.6 Key Strategy 115
15.2 Endo Pharmaceuticals Inc. 116
15.2.1 Company Overview 116
15.2.2 Financial Overview 116
15.2.3 Products Offering 117
15.2.4 Key Developments 117
15.2.5 SWOT Analysis 117
15.2.6 Key Strategy 117
15.3 PharmaJet, Inc 118
15.3.1 Company Overview 118
15.3.2 Financial Overview 118
15.3.3 Products Offering 118
15.3.4 Key Developments 118
15.3.5 SWOT Analysis 118
15.3.6 Key Strategy 119
15.4 Inovio Pharmaceuticals Inc. 120
15.4.1 Company Overview 120
15.4.2 Financial Overview 120
15.4.3 Products Offering 121
15.4.4 Key Developments 121
15.4.5 SWOT Analysis 121
15.4.6 Key Strategy 121
15.5 Medical International Technology, Inc. 122
15.5.1 Company Overview 122
15.5.2 Financial Overview 122
15.5.3 Products Offering 122
15.5.4 Key Developments 122
15.5.5 SWOT Analysis 123
15.5.6 Key Strategy 123
15.6 INJEX Pharma GmBH 124
15.6.1 Company Overview 124
15.6.2 Financial Overview 124
15.6.3 Products Offering 124
15.6.4 Key Developments 124
15.6.5 SWOT Analysis 124
15.6.6 Key Strategy 124
15.7 National Medical Products Inc. 125
15.7.1 Company Overview 125
15.7.2 Financial Overview 125
15.7.3 Products Offering 125
15.7.4 Key Developments 125
15.7.5 SWOT Analysis 125
15.7.6 Key Strategy 125
15.8 European Pharma Group 126
15.8.1 Company Overview 126
15.8.2 Financial Overview 126
15.8.3 Products Offering 126
15.8.4 Key Developments 126
15.8.5 SWOT Analysis 126
15.8.6 Key Strategy 126
15.9 PenJet Corporation 127
15.9.1 Company Overview 127
15.9.2 Financial Overview 127
15.9.3 Products Offering 127
15.9.4 SWOT Analysis 127
15.9.5 Key Strategy 127
15.10 Valeritas Holdings, Inc. 128
15.10.1 Company Overview 128
15.10.2 Financial Overview 128
15.10.3 Products Offering 128
15.10.4 Key Developments 128
15.10.5 SWOT Analysis 129
15.10.6 Key Strategy 129
15.11 CROSSJECT 130
15.11.1 Company Overview 130
15.11.2 Financial Overview 130
15.11.3 Products Offering 130
15.11.4 Key Developments 130
15.11.5 SWOT Analysis 130
15.11.6 Key Strategy 131
15.12 MIKA MEDICAL CO. 132
15.12.1 Company Overview 132
15.12.2 Financial Overview 132
15.12.3 Products Offering 132
15.12.4 Key Developments 132
15.12.5 SWOT Analysis 132
15.12.6 Key Strategy 132
15.13 D'Antonio Consultants International, Inc. 133
15.13.1 Company Overview 133
15.13.2 Financial Overview 133
15.13.3 Products Offering 133
15.13.4 Key Developments 133
15.13.5 SWOT Analysis 133
15.13.6 Key Strategy 133
16 Appendix
16.1 Discussion Blue Print 135
17 List Of Tables
TABLE 1 GLOBAL NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 34
TABLE 2 GLOBAL NEEDLE FREE INJECTION MARKET FOR FILLABLE NEEDLE-FREE INJECTORS 2020-2027 (USD MILLION) 35
TABLE 3 GLOBAL NEEDLE FREE INJECTION MARKET FOR PREFILLED NEEDLE-FREE INJECTORS 2020-2027 (USD MILLION) 35
TABLE 4 GLOBAL NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 37
TABLE 5 GLOBAL NEEDLE FREE INJECTION MARKET FOR JET-BASED 2020-2027 (USD MILLION) 38
TABLE 6 GLOBAL NEEDLE FREE INJECTION MARKET FOR SPRING-BASED 2020-2027 (USD MILLION) 38
TABLE 7 GLOBAL NEEDLE FREE INJECTION MARKET FOR LASER-POWERED 2020-2027 (USD MILLION) 38
TABLE 8 GLOBAL NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 40
TABLE 9 GLOBAL NEEDLE FREE INJECTION MARKET FOR REUSABLE NEEDLE-FREE INJECTORS 2020-2027 (USD MILLION) 41
TABLE 10 GLOBAL NEEDLE FREE INJECTION MARKET FOR DISPOSABLE NEEDLE-FREE INJECTORS 2020-2027 (USD MILLION) 41
TABLE 11 GLOBAL NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 43
TABLE 12 GLOBAL NEEDLE FREE INJECTION MARKET FOR LIQUID-BASED NEEDLE FREE INJECTORS 2020-2027 (USD MILLION) 44
TABLE 13 GLOBAL NEEDLE FREE INJECTION MARKET FOR POWDER-BASED NEEDLE FREE INJECTORS 2020-2027 (USD MILLION) 44
TABLE 14 GLOBAL NEEDLE FREE INJECTION MARKET FOR PROJECTILE/DEPOT-BASED NEEDLE FREE INJECTORS
2020-2027 (USD MILLION) 44
TABLE 15 GLOBAL NEEDLE FREE INJECTION MARKET BY, TYPE OF SITE OF DELIVERY 2020-2027 (USD MILLION) 46
TABLE 16 GLOBAL NEEDLE FREE INJECTION MARKET FOR INTRA DERMAL INJECTORS 2020-2027 (USD MILLION) 47
TABLE 17 GLOBAL NEEDLE FREE INJECTION MARKET FOR INTRAMUSCULAR INJECTORS 2020-2027 (USD MILLION) 47
TABLE 18 GLOBAL NEEDLE FREE INJECTION MARKET FOR SUBCUTANEOUS INJECTORS 2020-2027 (USD MILLION) 47
TABLE 19 GLOBAL NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 49
TABLE 20 GLOBAL NEEDLE FREE INJECTION MARKET FOR VACCINATION 2020-2027 (USD MILLION) 50
TABLE 21 GLOBAL NEEDLE FREE INJECTION MARKET FOR INSULIN DELIVERY 2020-2027 (USD MILLION) 50
TABLE 22 GLOBAL NEEDLE FREE INJECTION MARKET FOR ONCOLOGY 2020-2027 (USD MILLION) 50
TABLE 23 GLOBAL NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 52
TABLE 24 GLOBAL NEEDLE FREE INJECTION MARKET FOR HOSPITALS AND CLINICS 2020-2027 (USD MILLION) 53
TABLE 25 GLOBAL NEEDLE FREE INJECTION MARKET FOR AMBULATORY SURGICAL CENTRES 2020-2027 (USD MILLION) 53
TABLE 26 GLOBAL NEEDLE FREE INJECTION MARKET FOR HOMECARE SETTINGS 2020-2027 (USD MILLION) 53
TABLE 27 GLOBAL NEEDLE FREE INJECTION MARKET BY, REGION 2020-2027 (USD MILLION) 55
TABLE 28 AMERICAS NEEDLE FREE INJECTION MARKET BY, REGION 2020-2027 (USD MILLION) 56
TABLE 29 AMERICAS NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 56
TABLE 30 AMERICAS NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 57
TABLE 31 AMERICAS NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 57
TABLE 32 AMERICAS NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 57
TABLE 33 AMERICAS NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 57
TABLE 34 AMERICAS NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 58
TABLE 35 AMERICAS NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 58
TABLE 36 NORTH AMERICA NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 59
TABLE 37 NORTH AMERICA NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 59
TABLE 38 NORTH AMERICA NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 59
TABLE 39 NORTH AMERICA NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 60
TABLE 40 NORTH AMERICA NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 60
TABLE 41 NORTH AMERICA NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 60
TABLE 42 NORTH AMERICA NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 61
TABLE 43 U.S NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 61
TABLE 44 U.S NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 61
TABLE 45 U.S NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 62
TABLE 46 U.S NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 62
TABLE 47 U.S NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 62
TABLE 48 U.S NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 62
TABLE 49 U.S NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 63
TABLE 50 CANADA NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 63
TABLE 51 CANADA NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 63
TABLE 52 CANADA NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 64
TABLE 53 CANADA NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 64
TABLE 54 CANADA NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 64
TABLE 55 CANADA NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 64
TABLE 56 CANADA NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 65
TABLE 57 SOUTH AMERICA NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 65
TABLE 58 SOUTH AMERICA NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 65
TABLE 59 SOUTH AMERICA NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 66
TABLE 60 SOUTH AMERICA NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 66
TABLE 61 SOUTH AMERICA NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 66
TABLE 62 SOUTH AMERICA NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 66
TABLE 63 SOUTH AMERICA NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 67
TABLE 64 EUROPE NEEDLE FREE INJECTION MARKET BY, REGION 2020-2027 (USD MILLION) 68
TABLE 65 EUROPE NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 69
TABLE 66 EUROPE NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 69
TABLE 67 EUROPE NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 69
TABLE 68 EUROPE NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 69
TABLE 69 EUROPE NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 70
TABLE 70 EUROPE NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 70
TABLE 71 EUROPE NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 70
TABLE 72 WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 71
TABLE 73 WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 71
TABLE 74 WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 71
TABLE 75 WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 72
TABLE 76 WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 72
TABLE 77 WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 72
TABLE 78 WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 73
TABLE 79 GERMANY NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 73
TABLE 80 GERMANY NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 73
TABLE 81 GERMANY NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 74
TABLE 82 GERMANY NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 74
TABLE 83 GERMANY NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 74
TABLE 84 GERMANY NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 74
TABLE 85 GERMANY NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 75
TABLE 86 FRANCE NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 75
TABLE 87 FRANCE NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 75
TABLE 88 FRANCE NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 76
TABLE 89 FRANCE NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 76
TABLE 90 FRANCE NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 76
TABLE 91 FRANCE NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 76
TABLE 92 FRANCE NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 77
TABLE 93 U.K NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 77
TABLE 94 U.K NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 77
TABLE 95 U.K NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 78
TABLE 96 U.K NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 78
TABLE 97 U.K NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 78
TABLE 98 U.K NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 78
TABLE 99 U.K NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 79
TABLE 100 ITALY NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 79
TABLE 101 ITALY NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 79
TABLE 102 ITALY NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 80
TABLE 103 ITALY NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 80
TABLE 104 ITALY NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 80
TABLE 105 ITALY NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 80
TABLE 106 ITALY NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 81
TABLE 107 SPAIN NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 81
TABLE 108 SPAIN NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 81
TABLE 109 SPAIN NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 82
TABLE 110 SPAIN NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 82
TABLE 111 SPAIN NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 82
TABLE 112 SPAIN NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 82
TABLE 113 SPAIN NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 83
TABLE 114 REST OF WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 83
TABLE 115 REST OF WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 83
TABLE 116 REST OF WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 84
TABLE 117 REST OF WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 84
TABLE 118 REST OF WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 84
TABLE 119 REST OF WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 84
TABLE 120 REST OF WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 85
TABLE 121 EASTERN EUROPE NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 85
TABLE 122 EASTERN EUROPE NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 85
TABLE 123 EASTERN EUROPE NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 86
TABLE 124 EASTERN EUROPE NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 86
TABLE 125 EASTERN EUROPE NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 86
TABLE 126 EASTERN EUROPE NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 86
TABLE 127 EASTERN EUROPE NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 87
TABLE 128 ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, REGION 2020-2027 (USD MILLION) 88
TABLE 129 ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 88
TABLE 130 ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 89
TABLE 131 ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 89
TABLE 132 ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 89
TABLE 133 ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 89
TABLE 134 ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 90
TABLE 135 ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 90
TABLE 136 CHINA NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 91
TABLE 137 CHINA NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 91
TABLE 138 CHINA NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 91
TABLE 139 CHINA NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 92
TABLE 140 CHINA NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 92
TABLE 141 CHINA NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 92
TABLE 142 CHINA NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 93
TABLE 143 INDIA NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 93
TABLE 144 INDIA NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 93
TABLE 145 INDIA NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 94
TABLE 146 INDIA NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 94
TABLE 147 INDIA NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 94
TABLE 148 INDIA NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 94
TABLE 149 INDIA NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 95
TABLE 150 JAPAN NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 95
TABLE 151 JAPAN NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 95
TABLE 152 APAN NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 96
TABLE 153 JAPAN NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 96
TABLE 154 JAPAN NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 96
TABLE 155 JAPAN NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 96
TABLE 156 JAPAN NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 97
TABLE 157 SOUTH KOREA NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 97
TABLE 158 SOUTH KOREA NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 97
TABLE 159 SOUTH KOREA NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 98
TABLE 160 SOUTH KOREA NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 98
TABLE 161 SOUTH KOREA NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 98
TABLE 162 SOUTH KOREA NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 98
TABLE 163 SOUTH KOREA NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 99
TABLE 164 REST OF ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 99
TABLE 165 REST OF ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 99
TABLE 166 REST OF ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 100
TABLE 167 REST OF ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 100
TABLE 168 REST OF ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 100
TABLE 169 REST OF ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 100
TABLE 170 REST OF ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 101
TABLE 171 MIDDLE EAST & AFRICA NEEDLE FREE INJECTION MARKET BY, REGION 2020-2027 (USD MILLION) 102
TABLE 172 MIDDLE EAST & AFRICA NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 102
TABLE 173 MIDDLE EAST & AFRICA NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 103
TABLE 174 MIDDLE EAST & AFRICA NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 103
TABLE 175 MIDDLE EAST & AFRICA NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 103
TABLE 176 MIDDLE EAST & AFRICA NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 103
TABLE 177 MIDDLE EAST & AFRICA NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 104
TABLE 178 MIDDLE EAST & AFRICA NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 104
TABLE 179 THE MIDDLE EAST NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 105
TABLE 180 THE MIDDLE EAST NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 105
TABLE 181 THE MIDDLE EAST NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 105
TABLE 182 THE MIDDLE EAST NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 106
TABLE 183 THE MIDDLE EAST NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 106
TABLE 184 THE MIDDLE EAST NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 106
TABLE 185 THE MIDDLE EAST NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 107
TABLE 186 AFRICA NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 107
TABLE 187 AFRICA NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 107
TABLE 188 AFRICA NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 108
TABLE 189 AFRICA NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 108
TABLE 190 AFRICA NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 108
TABLE 191 AFRICA NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 108
TABLE 192 AFRICA NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 109
18 List Of Figures
FIGURE 1 MARKET STRUCTURE 19
FIGURE 2 RESEARCH PROCESS 21
FIGURE 3 DROC ANALYSIS OF GLOBAL NEEDLE FREE INJECTION MARKET 24
FIGURE 4 DRIVERS IMPACT ANALYSIS: GLOBAL NEEDLE FREE INJECTION MARKET 25
FIGURE 5 RESTRAINTS IMPACT ANALYSIS: NEEDLE FREE INJECTION MARKET 26
FIGURE 6 VALUE CHAIN: GLOBAL NEEDLE-FREE INJECTION MARKET 29
FIGURE 7 PORTER’S FIVE FORCES MODEL: GLOBAL NEEDLE-FREE INJECTION MARKET 31
FIGURE 8 GLOBAL NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020 & 2027 (USD MILLION) 34
FIGURE 9 GLOBAL NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020 & 2027 (USD MILLION) 37
FIGURE 10 GLOBAL NEEDLE FREE INJECTION MARKET BY, USABILITY 2020 & 2027 (USD MILLION) 40
FIGURE 11 GLOBAL NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020 & 2027 (USD MILLION) 43
FIGURE 12 GLOBAL NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020 & 2027 (USD MILLION) 46
FIGURE 13 GLOBAL NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020 & 2027 (USD MILLION) 49
FIGURE 14 GLOBAL NEEDLE FREE INJECTION MARKET BY, END USER 2020 & 2027 (USD MILLION) 52
FIGURE 15 GLOBAL NEEDLE FREE INJECTION MARKET SHARE BY, REGION 2020 (%) 55
FIGURE 16 AMERICAS NEEDLE FREE INJECTION MARKET SAHRE BY, REGION 2020 (%) 56
FIGURE 17 EUROPE NEEDLE FREE INJECTION MARKET SAHRE BY, REGION 2020 (%) 68
FIGURE 18 ASIA PACIFIC NEEDLE FREE INJECTION MARKET SAHRE BY, REGION 2020 (%) 88
FIGURE 19 MIDDLE EAST & AFRICA NEEDLE FREE INJECTION MARKET SAHRE BY, REGION 2020 (%) 102
FIGURE 20 GLOBAL NEEDLE FREE INJECTION MARKET, COMPETITIVE LANDSCAPE, 2020 (%) 111